Clinical trials are research studies that explore whether a medical treatment is safe and effective.
The Stanford ILD Program has a longstanding history of participation in clinical trials related to interstitial lung disease, including clinical trials sponsored by the NIH, Stanford investigators, or industry. Our team of investigators and research coordinators would be happy to discuss clinical trial opportunities at Stanford. Please contact Stanford’s ILD research nurse manager for more information.
The opportunity to be part of a clinical trial offers hope to patients, hope for a new and more effective treatment or one with less harmful side effects than the standard treatment. Trial participation also means to patients that they are helping the advancement of science and consequently it could be benefiting other patients.
- Karen Morris PhD, CRC